Purchase Order 36C26120P0754
Award Date
3/21/20
Potential Completion Date
3/28/20
Potential Value
$93K
Federal Agency
Veterans Integrated Service Network 21
Awardee
Accredo Health Group, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Palo Alto, CA 94304, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company. The contract, valued at $94,899.21, is for the delivery of the drug Tyvaso, which is used to treat pulmonary arterial hypertension. The contract is not associated with a larger contract vehicle and does not have a set-aside designation. Accredo Health Group, Inc. is the prime contractor and there are no major...
This is a $81,632.25 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit subsidiary of Express Scripts that specializes in providing specialty pharmaceutical services. The contract is for the delivery of the medication Tyvaso, which is used to treat pulmonary arterial hypertension. The contract has no set-aside designation and was awarded on April 6, 2021, with a completion date of September 30, 2021....
The U.S. Department of Veterans Affairs (VA) awarded a $81,342.18 firm fixed-price purchase order contract to Accredo Health Group, Inc., a for-profit pharmacy benefit management company, to provide the specialty pharmaceutical TYVASO. The contract, which does not have a set-aside designation, is to support the VA's Veterans Integrated Service Network 21 (VISN 21) and has an ultimate completion date of September 30, 2022. Accredo Health Group, Inc. is a key distributor of complex and...
This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 21 to Accredo Health Group, Inc., a for-profit pharmacy benefit management company, for the delivery of the specialty pharmaceutical Tyvaso. The total ceiling value of the contract is $81,342.18, with a period of performance through September 30, 2022. Accredo Health Group, Inc. is a key distributor of complex and high-value medications, primarily serving the...
This is a $113,770.56 firm fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company. The contract is for the delivery of TYVASCO 0.6 MG, a specialty pharmaceutical product, to support veterans' healthcare through the VA's Veterans Integrated Service Network 21. The contract does not have a set-aside designation and will be performed at Accredo's...
This is a $40,697.68 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company. The contract is for the supply of specialty pharmaceutical products, including medications to treat pulmonary arterial hypertension, neuropathic lysosomal storage disorders, and ophthalmic disorders. The contract has an ultimate completion date of March 14, 2025 and is part of the VA's Veterans...
The Department of Veterans Affairs Veterans Health Administration awarded a $13,557 purchase order to Accredo Health Group, Inc. to deliver TYVASO in Palo Alto, California from January 18, 2023 through April 18, 2023. As a prime contractor supporting VA's Veterans Integrated Service Network 21, Accredo Health Group will provide the pulmonary arterial hypertension medication on a firm fixed price basis. No subcontractors or set aside designations were indicated. This purchase order was issued...
This is a $103,003.20 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company specializing in specialty pharmaceutical services. The contract is for the delivery of various complex and high-value medications, primarily to support the VA's Veterans Integrated Service Network (VISN) healthcare facilities. Key medications provided under this contract include drugs used to treat...
This firm fixed-price purchase order was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 16 to Accredo Health Group, Inc., a for-profit pharmacy benefit management company, to provide the specialty pharmaceutical drug Uptravi-Selexipag. The $144,743.29 contract has a completion date of March 17, 2022 and supports the VHA's distribution of critical medications to treat pulmonary arterial hypertension for patients and...
This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company. The contract is for the delivery of UPTRAVI 1600MCG, a medication used to treat pulmonary arterial hypertension, under a larger VA contract vehicle (36F79719D0142). The contract has a ceiling value of $166,022.23 and a performance period ending on January 11, 2025. Accredo Health Group, Inc. is a subsidiary of...